Φορτώνει......
Vincristine/Irinotecan Upfront Window Treatment of High-risk Hepatoblastoma: A Report from the Children’s Oncology Group (COG) AHEP0731 Study Committee
PURPOSE: The identification of new therapies for high-risk (HR) hepatoblastoma (HB) is challenging. Children’s Oncology Group Study AHEP0731 included a HR stratum to explore the efficacy of novel agents. We report the response rate to vincristine/irinotecan and the outcome of high-risk HB patients....
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cancer |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5665173/ https://ncbi.nlm.nih.gov/pubmed/28211941 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30591 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|